{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:19:11Z","timestamp":1790191151905,"version":"4.1.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jaac.2020.09.025","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T19:00:06Z","timestamp":1609268406000},"page":"937-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treating Autism With Bumetanide: Are Large Multicentric and Monocentric Trials on Selected Populations Complementary?"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4621-0444","authenticated-orcid":false,"given":"Eric","family":"Lemonnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6282-8020","authenticated-orcid":false,"given":"Hamed","family":"Rabiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Makowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-3106","authenticated-orcid":false,"given":"Nouchine","family":"Hadjikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6208-8480","authenticated-orcid":false,"given":"Yehezkel","family":"Ben-Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2020.09.025_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2020.07.888","article-title":"Bumetanide for core symptoms of autism spectrum disorders (BAMBI): A single center, double blinded, participant randomized placebo-controlled, phase two superiority trial","author":"Sprengers","year":"2021","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2020.09.025_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/cap.2015.0045","article-title":"(2015): A pilot study on the combination of applied behavioral analysis and bumetanide treatment of children with autism","volume":"25","author":"Du","year":"2015","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2020.09.025_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41398-020-0692-2","article-title":"Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decrease GABA\/glutamate ratio [published correction appears in Transl Psychiatry. 2020;10:63]","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jaac.2020.09.025_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13229-020-00335-4","article-title":"Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open label pilot study","volume":"11","author":"van Andel","year":"2020","journal-title":"Mol Autism"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856720322243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856720322243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:30:59Z","timestamp":1760193059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856720322243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0890856720322243"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2020.09.025","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating Autism With Bumetanide: Are Large Multicentric and Monocentric Trials on Selected Populations Complementary?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2020.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}